LivaNova(LIVN) - 2025 Q2 - Quarterly Results

LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidance EXHIBIT 99.1 NEWS RELEASE – Delivered double-digit reported and organic revenue growth and continued operating margin expansion – Raised full-year 2025 revenue, adjusted earnings per share, and adjusted free cash flow guidance (1) – Initiated process with U.S. Centers for Medicare and Medicaid Services for reconsideration of national coverage for VNS Therapy™ for treatment-resistant depression – Announced long-term, real-world evidence demon ...